title: Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.
abstract: OBJECTIVE
  To determine whether persons in a community setting diagnosed with diabetes who received recommended patterns of care experience improved vision outcomes over a 3-year time period.
  
  
  METHODS
  Retrospective, longitudinal, cohort analysis.
  
  
  METHODS
  Persons diagnosed with diabetes mellitus (DM), with no prior diagnosis of diabetic retinopathy (DR; n = 5989) from the Medicare Current Beneficiary Survey (1992-2004). Persons diagnosed with DM were followed up to 3 years.
  
  
  METHODS
  Propensity score matching was used to compare vision outcomes between persons who received guideline-recommended care and those who did not. Receipt of recommended levels of care was defined as receiving each of the following services 0.75 times annually on average: physician examination, ophthalmologist or optometrist examination, hemoglobin A1c level, lipid levels, and urinalysis.
  
  
  METHODS
  Outcome measures were indicators of DR disease progression: no diagnosed DR to diagnosed background DR, proliferative DR, macular edema, proliferative DR complications, and use of a low-vision aid or blindness.
  
  
  RESULTS
  Persons with diagnosed diabetes receiving guideline-recommended care experienced earlier onset of background DR (average treatment effects on the treated [ATT] at 3 years, 0.118; 95% confidence interval [CI], -0.005 to 0.240). There were no differences between those receiving recommended care and others in time to onset of proliferative DR, macular edema, or proliferative DR complications. However, persons who received care consistent with recommendations experienced much lower rates of onset of low vision/blindness than did others (ATT at 3 years, -0.109; 95% CI, -0.189 to -0.030).
  
  
  CONCLUSIONS
  Low vision/blindness was substantially reduced over a 3-year period among persons diagnosed with DM who received recommended levels of care.
authors: Center for Health Policy, Duke University, Durham, North Carolina 27708, USA. fsloan@duke.edu
authors: Frank A
authors: FA
authors: Sloan
authors: Daniel S
authors: DS
authors: Grossman
authors: Paul P
authors: PP
authors: Lee
mesh_terms: D000368:Aged; D001766:Blindness / Q000175:diagnosis / Q000503:physiopathology; D003695:Delivery of Health Care / Q000592:standards*; D003920:Diabetes Mellitus / Q000175:diagnosis*; D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D015354:Vision, Low / Q000175:diagnosis / Q000503:physiopathology
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human